57894-080-90 : NDC 2026 Code

57894-080-90 : Lazertinib ( Lazcluze )

Additionally :

You can get information about “57894-080-90” NDC code in 57894-080-90 in HTML format

HTML | 57894-080-90 in TXT (Plain Text) format

TXT | 57894-080-90 in PDF (Portable Document Format)

PDF | 57894-080-90 in XML format

XML formats.

NDC Code : 57894-080-90 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "57894-080-90",
    "PackageDescription": "1 BOTTLE in 1 CARTON (57894-080-90)  / 90 TABLET, FILM COATED in 1 BOTTLE",
    "NDC11Code": "57894-0080-90",
    "ProductNDC": "57894-080",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lazcluze",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lazertinib",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20240820",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219008",
    "LabelerName": "Janssen Biotech, Inc.",
    "SubstanceName": "LAZERTINIB",
    "StrengthNumber": "80",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-25",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240820",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}